Alaunos Therapeutics
TCRT
TCRT
89 hedge funds and large institutions have $7.36M invested in Alaunos Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 28 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
65% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 17
78% less capital invested
Capital invested by funds: $34.2M → $7.36M (-$26.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
89
Holding in Top 10
–
Calls
$1.07M
Puts
$11K
Top Buyers
| 1 | +$43.1K | |
| 2 | +$32.8K | |
| 3 | +$9.84K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$5.62K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.91K |
Top Sellers
| 1 | -$2.92M | |
| 2 | -$318K | |
| 3 | -$256K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$120K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$63K |